Q1 2024 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2024-05-15 · accession 0001104659-24-061946
$646.4M
Reported value
39
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $120.6M | 18.7% | 6,788,609 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $92.0M | 14.2% | 4,121,689 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $65.5M | 10.1% | 5,074,916 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $64.5M | 9.98% | 1,267,790 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $40.7M | 6.30% | 3,768,035 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $31.6M | 4.88% | 453,641 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $27.0M | 4.17% | 1,208,473 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $17.3M | 2.68% | 2,780,261 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $17.0M | 2.63% | 2,523,022 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $16.3M | 2.53% | 967,527 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $15.4M | 2.38% | 525,000 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $15.3M | 2.37% | 1,458,875 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $13.3M | 2.06% | 799,274 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $12.2M | 1.88% | 850,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $12.0M | 1.85% | 1,562,500 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $9.6M | 1.48% | 1,786,427 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $9.5M | 1.46% | 1,675,579 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.5M | 1.16% | 172,647 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $7.2M | 1.12% | 6,130,268 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $6.8M | 1.05% | 180,207 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $6.3M | 0.97% | 3,640,015 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $5.6M | 0.87% | 347,500 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $5.0M | 0.77% | 630,000 | Common | SOLE |
| 918385204 | VTVT | VTV THERAPEUTICS INC | $4.9M | 0.75% | 206,784 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $4.2M | 0.64% | 396,000 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $4.1M | 0.64% | 291,666 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $3.8M | 0.59% | 540,304 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $3.2M | 0.50% | 196,425 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $1.8M | 0.28% | 669,303 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.5M | 0.23% | 154,664 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.5M | 0.23% | 1,049,153 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.3M | 0.21% | 202,348 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $863,252 | 0.13% | 696,171 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $703,503 | 0.11% | 689,709 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $216,832 | 0.03% | 172,089 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $101,570 | 0.02% | 78,131 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $62,155 | 0.01% | 82,336 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $40,333 | 0.01% | 133,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,020 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.